505 related articles for article (PubMed ID: 7937106)
1. A residue of the ETS domain mutated in the v-ets oncogene is essential for the DNA-binding and transactivating properties of the ETS-1 and ETS-2 proteins.
Soudant N; Albagli O; Dhordain P; Flourens A; Stéhelin D; Leprince D
Nucleic Acids Res; 1994 Sep; 22(19):3871-9. PubMed ID: 7937106
[TBL] [Abstract][Full Text] [Related]
2. A model for gene evolution of the ets-1/ets-2 transcription factors based on structural and functional homologies.
Albagli O; Soudant N; Ferreira E; Dhordain P; Dewitte F; Begue A; Flourens A; Stehelin D; Leprince D
Oncogene; 1994 Nov; 9(11):3259-71. PubMed ID: 7936650
[TBL] [Abstract][Full Text] [Related]
3. An inhibitory carboxyl-terminal domain in Ets-1 and Ets-2 mediates differential binding of ETS family factors to promoter sequences of the mb-1 gene.
Hagman J; Grosschedl R
Proc Natl Acad Sci U S A; 1992 Oct; 89(19):8889-93. PubMed ID: 1409581
[TBL] [Abstract][Full Text] [Related]
4. c-ets-1 DNA binding to the PEA3 motif is differentially inhibited by all the mutations found in v-ets.
Leprince D; Crepieux P; Stehelin D
Oncogene; 1992 Jan; 7(1):9-17. PubMed ID: 1741168
[TBL] [Abstract][Full Text] [Related]
5. A new mechanism of oncogenic activation: E26 retroviral v-ets oncogene has inverted the C-terminal end of the transcription factor c-ets-1.
Leprince D; Crepieux P; Laudet V; Flourens A; Stehelin D
Virology; 1993 Jun; 194(2):855-7. PubMed ID: 8389086
[TBL] [Abstract][Full Text] [Related]
6. p54c-ets-1 and p68c-ets-1, the two transcription factors encoded by the c-ets-1 locus, are differentially expressed during the development of the chick embryo.
Quéva C; Leprince D; Stéhelin D; Vandenbunder B
Oncogene; 1993 Sep; 8(9):2511-20. PubMed ID: 8361762
[TBL] [Abstract][Full Text] [Related]
7. DNA binding by c-Ets-1, but not v-Ets, is repressed by an intramolecular mechanism.
Lim F; Kraut N; Framptom J; Graf T
EMBO J; 1992 Feb; 11(2):643-52. PubMed ID: 1311254
[TBL] [Abstract][Full Text] [Related]
8. Phylogeny of the p68c-ets-1 amino-terminal transactivating domain reveals some highly conserved structural features.
Albagli O; Flourens A; Crepieux P; Begue A; Stehelin D; Leprince D
Oncogene; 1992 Jul; 7(7):1435-9. PubMed ID: 1620554
[TBL] [Abstract][Full Text] [Related]
9. The chicken cellular progenitor of the v-ets oncogene, p68c-ets-1, is a nuclear DNA-binding protein not expressed in lymphoid cells of the spleen.
Leprince D; Gesquiere JC; Stehelin D
Oncogene Res; 1990; 5(4):255-65. PubMed ID: 2204018
[TBL] [Abstract][Full Text] [Related]
10. v-Rel and c-Rel are differentially affected by mutations at a consensus protein kinase recognition sequence.
Mosialos G; Gilmore TD
Oncogene; 1993 Mar; 8(3):721-30. PubMed ID: 8437855
[TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of the ets genes and their products.
Watson DK; Ascione R; Papas TS
Crit Rev Oncog; 1990; 1(4):409-36. PubMed ID: 1964597
[TBL] [Abstract][Full Text] [Related]
12. ERF: an ETS domain protein with strong transcriptional repressor activity, can suppress ets-associated tumorigenesis and is regulated by phosphorylation during cell cycle and mitogenic stimulation.
Sgouras DN; Athanasiou MA; Beal GJ; Fisher RJ; Blair DG; Mavrothalassitis GJ
EMBO J; 1995 Oct; 14(19):4781-93. PubMed ID: 7588608
[TBL] [Abstract][Full Text] [Related]
13. Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2.
Yang BS; Hauser CA; Henkel G; Colman MS; Van Beveren C; Stacey KJ; Hume DA; Maki RA; Ostrowski MC
Mol Cell Biol; 1996 Feb; 16(2):538-47. PubMed ID: 8552081
[TBL] [Abstract][Full Text] [Related]
14. Myb and Ets transcription factors cooperate at the myb-inducible promoter of the tom-1 gene.
Burk O; Klempnauer KH
Biochim Biophys Acta; 1999 Sep; 1446(3):243-52. PubMed ID: 10524199
[TBL] [Abstract][Full Text] [Related]
15. Transactivation of GATA-1 promoter with ETS1, ETS2 and ERGB/Hu-FLI-1 proteins: stabilization of the ETS1 protein binding on GATA-1 promoter sequences by monoclonal antibody.
Seth A; Robinson L; Thompson DM; Watson DK; Papas TS
Oncogene; 1993 Jul; 8(7):1783-90. PubMed ID: 8510925
[TBL] [Abstract][Full Text] [Related]
16. A novel modulator domain of Ets transcription factors.
Wasylyk C; Kerckaert JP; Wasylyk B
Genes Dev; 1992 Jun; 6(6):965-74. PubMed ID: 1592263
[TBL] [Abstract][Full Text] [Related]
17. Regulation of gene expression by transcription factors Ets-1 and Ets-2.
Tymms MJ; Kola I
Mol Reprod Dev; 1994 Oct; 39(2):208-14. PubMed ID: 7826624
[TBL] [Abstract][Full Text] [Related]
18. The oncoprotein v-Ets is less selective in DNA binding than c-Ets-1 due to the C-terminal sequence change.
Hahn SL; Wasylyk B
Oncogene; 1994 Sep; 9(9):2499-512. PubMed ID: 8058313
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic conversion alters the transcriptional properties of ets.
Wasylyk C; Wasylyk B
Cell Growth Differ; 1992 Sep; 3(9):617-25. PubMed ID: 1329927
[TBL] [Abstract][Full Text] [Related]
20. erg, an ets-related gene, codes for sequence-specific transcriptional activators.
Reddy ES; Rao VN
Oncogene; 1991 Dec; 6(12):2285-9. PubMed ID: 1766675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
